Tylosin
is used in livestock for various purposes such as a feed additive for
growth promotion and as an antibiotic against infectious diseases in
animals such as chickens, turkeys, felines, canines, pigs, calves,
and others. These antibiotics aid in the treatment of chronic
respiratory disease (CRD) associated with Mycoplasma Gallisepticum
and Mycolplasma synoviae and other infections.
Tylosin
is used for treatment and control of swine dysentery associated with
Brachyspira Hyodysenteriae and for the control of porcine proliferate
enteropathies in pigs. Moreover, Tylosin is highly effective in
tylosin-responsive diarrhea in dogs, which is a canine chronic,
recurrent diarrhea that responds repeatedly to Tylosin treatment.
Request
Free Sample Copy @
https://www.coherentmarketinsights.com/insight/request-sample/2061
Market
Dynamics
The
global Tylosin market is expected to witness significant growth over
the forecast period, owing to rising demand for Tylosin in livestock
industry. For instance, according to a study by Ministry for Primary
Industries, New Zealand 2016, Tylosin accounted for over 83% of
macrolide and lincosamide sales during 2011 and 2014 and the trend is
expected to continue over the forecast period.
Moreover,
certain mergers and acquisitions are expected to boost the market
growth over the forecast period. For instance, Eily, Lilly, and
Company acquired Novartis Animal Health in 2014. Varied product
offering by manufacturers such as Elanco Animal Health is expected to
propel the global Tylosin market growth over the forecast period. For
instance, Elanco offers Component with Tylan, an implant line with
initial and terminal implants for steers and heifers. This implant
includes a tylosin tartrate (Tylan) pellet that dissolves and
releases antibacterial throughout the implant site.
The
global Tylosin market size was valued at US$ 379.0 million in 2017,
and is expected to witness a CAGR of 1.2% over the forecast period
(2018 – 2026).
Increasing
demand for healthy livestock is expected to support growth of global
Tylosin market over the forecast period
The
demand for livestock animals for consumption is on the rise worldwide
and is expected to maintain the positive growth in demand over the
forecast period. Subsequently, the demand for infection-free and
healthy livestock used primarily for consumption is increasing.
However, the prevalence of various microbial infections is high in
both humans and animals. For instance, according to the Centers for
Disease Control and Prevention (CDC), 2017, zoonotic diseases are
common in the U.S. and worldwide and over 6 out of every 10 known
infectious diseases in humans are spread from animals. Hence,
antibiotics are an important medication for livestock that aide in
providing healthy food products for consumption in humans.
Key
players operating in the global Tylosin market include Zoetis, Tairui
Pharmaceuticals, Lukang Pharmaceutical, Henan Hualun, Qilu
Pharmaceutical (Inner Mongolia) Co., Ltd, Huvepharma, AdvaCare
Pharma, and Elanco Animal Health.
Detailed
Segmentation:
Global
Tylosin Market, By Drug Type:
-
Tylosin Phosphate
-
Tylosin Tartrate
-
Others
Global
Tylosin Market, By Application:
-
Felines
-
Canines
-
Livestock
-
Others
Global
Tylosin Market, By Route Of Administration:
-
Oral
-
Injectable
Get
Full Access of This Business Report:
https://www.coherentmarketinsights.com/market-insight/tylosin-market-2061
About
Coherent Market Insights:
Coherent
Market Insights is a prominent market research and consulting firm
offering action-ready syndicated research reports, custom market
analysis, consulting services, and competitive analysis through
various recommendations related to emerging market trends,
technologies, and potential absolute dollar opportunity.
Contact
Us:
Mr.
Shah
Coherent
Market Insights
1001
4th Ave,
#3200
Seattle,
WA 98154
Tel:
+1-206-701-6702
No comments:
Post a Comment